Bharat Biotech Tries Intradermal Route for COVID-19 Vaccine, an Industrial Info Market Brief

Bharat Biotech International Limited, India's leading vaccine maker, is preparing for clinical trials of its COVID-19 vaccine candidate Covaxin, administering it through an intradermal route. The company has received permission from India's Central Drugs Standard Control Organization (CDSCO) to take up the trial.